# Applied DNA Sciences Inc. (APDN)

Source: https://www.quantisnow.com/company/APDN
Generated: 2026-11-13T16:42:12.095Z

- Ticker: APDN
- Exchange: NASDAQ
- Sector: Consumer Discretionary
- Industry: Other Consumer Services
- Website: adnas.com

## About

Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes applications in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications and can be used to fortify brand protection efforts, and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide definitive real-time authentication of molecular tags in the field; and CertainT Supply Chain Platform that provides proof of product claims for materials, items, or products. It also manufactures and sells COVID-19 PCR-based molecular diagnostic test kit under the LineaTM COVID-19 Assay Kit trademark; and non-diagnostic COVID-19 pooled surveillance testing to detect instances of COVID-19 in defined populations under the safeCircle trademark. In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and contract research services to RNA based drug and biologic customers for preclinical studies. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.

## Latest APDN news and filings

- 2025-11-17 21:39 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Applied DNA Sciences Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-applied-dna-sciences-inc-6283170)
- 2025-11-17 21:36 UTC [SEC Form 8-K] [Applied DNA Sciences Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/applied-dna-sciences-inc-filed-sec-form-8-k-amendments-to-6283154)
- 2025-11-14 13:14 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Applied DNA Sciences Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-applied-dna-sciences-6279125)
- 2025-11-10 22:01 UTC [SEC Form 8-K] [Applied DNA Sciences Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/applied-dna-sciences-inc-filed-sec-form-8-k-leadership-update-6271331)
- 2025-11-10 21:55 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Applied DNA Sciences Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-applied-dna-sciences-inc-6271268)
- 2025-11-04 13:31 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Applied DNA Sciences Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-applied-dna-sciences-inc-6258320)
- 2025-11-04 13:08 UTC [SEC Form 8-K] [Applied DNA Sciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/applied-dna-sciences-inc-filed-sec-form-8-k-entry-into-6258225)
- 2025-10-30 20:44 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Applied DNA Sciences Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-applied-dna-sciences-inc-6253045)
- 2025-10-30 00:01 UTC [SEC Form S-1] [SEC Form S-1 filed by Applied DNA Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-1-filed-by-applied-dna-sciences-inc-6250791)
- 2025-10-23 01:06 UTC [SEC Form 8-K] [Applied DNA Sciences Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/applied-dna-sciences-inc-filed-sec-form-8-k-other-events-6242358)
- 2025-10-20 21:06 UTC [SEC Form 4] [Director Ceccoli Joseph D. was granted 22,511 shares, increasing direct ownership by 2,251,100% to 22,512 units (SEC Form 4)](https://www.quantisnow.com/insight/director-ceccoli-joseph-d-was-granted-22511-shares-increasing-direct-6238750)
- 2025-10-20 21:03 UTC [SEC Form 4] [Chief Financial Officer Jantzen Beth was granted 18,691 shares, increasing direct ownership by 623,033% to 18,694 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-jantzen-beth-was-granted-18691-shares-increasing-6238740)
- 2025-10-20 21:00 UTC [SEC Form 4] [Director Murrah Judith was granted 18,691 shares, increasing direct ownership by 623,033% to 18,694 units (SEC Form 4)](https://www.quantisnow.com/insight/director-murrah-judith-was-granted-18691-shares-increasing-direct-ownership-6238738)
- 2025-10-20 21:01 UTC [SEC Form 4] [Director Shamash Yacov A was granted 22,511 shares, increasing direct ownership by 2,251,100% to 22,512 units (SEC Form 4)](https://www.quantisnow.com/insight/director-shamash-yacov-a-was-granted-22511-shares-increasing-direct-6238737)
- 2025-10-20 21:04 UTC [SEC Form 4] [Director Catell Robert B was granted 22,511 shares, increasing direct ownership by 2,251,100% to 22,512 units (SEC Form 4)](https://www.quantisnow.com/insight/director-catell-robert-b-was-granted-22511-shares-increasing-direct-6238736)
- 2025-10-20 20:57 UTC [SEC Form 4] [Chief Executive Officer Shorrock Clay was granted 18,691 shares, increasing direct ownership by 467,275% to 18,695 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-shorrock-clay-was-granted-18691-shares-increasing-6238735)
- 2025-10-20 21:02 UTC [SEC Form 4] [Director Schmalz Elizabeth M was granted 22,511 shares, increasing direct ownership by 2,251,100% to 22,512 units (SEC Form 4)](https://www.quantisnow.com/insight/director-schmalz-elizabeth-m-was-granted-22511-shares-increasing-direct-6238733)
- 2025-10-15 00:59 UTC [SEC Form D] [SEC Form D filed by Applied DNA Sciences Inc.](https://www.quantisnow.com/insight/sec-form-d-filed-by-applied-dna-sciences-inc-6233078)
- 2025-10-06 20:06 UTC [SEC Form 8-K] [Applied DNA Sciences Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/applied-dna-sciences-inc-filed-sec-form-8-k-costs-associated-6224596)
- 2025-10-06 12:00 UTC [Mergers & Acquisitions] [Applied DNA Sciences to Begin Trading Under New Ticker 'BNBX' Reflecting Digital Asset Treasury Strategy](https://www.quantisnow.com/insight/applied-dna-sciences-to-begin-trading-under-new-ticker-bnbx-6223912)
- 2025-10-01 14:08 UTC [SEC Form 8-K] [Applied DNA Sciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/applied-dna-sciences-inc-filed-sec-form-8-k-entry-into-6217567)
- 2025-09-29 20:01 UTC [SEC Form 8-K] [Applied DNA Sciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Other Events](https://www.quantisnow.com/insight/applied-dna-sciences-inc-filed-sec-form-8-k-entry-into-6214361)
- 2025-09-29 19:08 UTC [Conference Announcement] [Applied DNA Sciences Announces Private Placement of Up To $58 Million To Initiate BNB Treasury Strategy and BNB Native Yield Generation](https://www.quantisnow.com/insight/applied-dna-sciences-announces-private-placement-of-up-to-58-6214304)
- 2025-09-23 12:30 UTC [Market Insight] [Applied DNA Abstracts Selected for Poster Presentations Showcasing LineaDNA and LineaIVT Platforms at Upcoming mRNA and CAR T Industry Conferences](https://www.quantisnow.com/insight/applied-dna-abstracts-selected-for-poster-presentations-showcasing-lineadna-and-6208963)
- 2025-08-15 01:42 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Applied DNA Sciences Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-applied-dna-sciences-6167584)
- 2025-08-14 20:16 UTC [SEC Form 8-K] [Applied DNA Sciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/applied-dna-sciences-inc-filed-sec-form-8-k-results-of-6166357)
- 2025-08-14 20:10 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Applied DNA Sciences Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-applied-dna-sciences-inc-6166199)
- 2025-08-14 20:10 UTC [Market Insight] [Applied DNA Reports Third Quarter Fiscal 2025 Financial Results](https://www.quantisnow.com/insight/applied-dna-reports-third-quarter-fiscal-2025-financial-results-6165875)
- 2025-07-24 22:29 UTC [SEC Form S-8] [SEC Form S-8 filed by Applied DNA Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-applied-dna-sciences-inc-6132308)
- 2025-07-24 13:00 UTC [Market Insight] [Applied DNA Announces New Follow-On LineaDNA Order from Global IVD Manufacturer for Use in Cancer Diagnostic Application](https://www.quantisnow.com/insight/applied-dna-announces-new-follow-on-lineadna-order-from-global-ivd-6131058)
- 2025-07-07 20:05 UTC [SEC Form 8-K] [Applied DNA Sciences Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/applied-dna-sciences-inc-filed-sec-form-8-k-other-events-6112661)
- 2025-07-07 13:00 UTC [Market Insight] [Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements](https://www.quantisnow.com/insight/applied-dna-regains-compliance-with-all-nasdaq-continued-listing-requirements-6112329)
- 2025-06-30 20:05 UTC [SEC Form 8-K] [Applied DNA Sciences Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/applied-dna-sciences-inc-filed-sec-form-8-k-costs-associated-6103636)
- 2025-06-30 13:00 UTC [Market Insight] [Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx](https://www.quantisnow.com/insight/applied-dna-sharpens-strategic-focus-on-synthetic-dna-manufacturing-for-6103093)
- 2025-06-17 20:15 UTC [SEC Form 8-K] [Applied DNA Sciences Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/applied-dna-sciences-inc-filed-sec-form-8-k-leadership-update-6089965)
- 2025-06-17 20:10 UTC [Market Insight] [Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward](https://www.quantisnow.com/insight/applied-dna-announces-retirement-of-chairperson-and-ceo-dr-james-6089902)
- 2025-06-16 13:00 UTC [Market Insight] [Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August](https://www.quantisnow.com/insight/applied-dna-to-resume-quarterly-investor-call-cadence-beginning-with-6087412)
- 2025-06-06 18:28 UTC [SEC Form 8-K] [Applied DNA Sciences Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/applied-dna-sciences-inc-filed-sec-form-8-k-notice-of-6075974)
- 2025-05-29 20:05 UTC [Market Insight] [Applied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17](https://www.quantisnow.com/insight/applied-dna-reschedules-intra-quarter-webcast-and-investor-update-call-to-6063008)
- 2025-05-29 12:15 UTC [SEC Form 8-K] [Applied DNA Sciences Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/applied-dna-sciences-inc-filed-sec-form-8-k-amendments-to-6062468)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/APDN
- Earnings history: https://www.quantisnow.com/earnings/APDN
- Dividend history: https://www.quantisnow.com/dividends/APDN
- Insider transactions: https://www.quantisnow.com/insiders/APDN
- Options chain: https://www.quantisnow.com/options/APDN
- SEC 8-K filings only: https://www.quantisnow.com/company/APDN/8-k
- RSS and alerts for APDN: https://www.quantisnow.com/docs/rss-feeds.md